Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and nice to see you again. We are back from an extended weekend, of sorts, since we did stop to provide coverage of breaking news at one point. In any event, the extra time away was enjoyable and we hope that you similarly had a refreshing break. Now, of course, the routine of meetings and deadlines has resumed. After all, we are in the midst of the busy season. So please join us as we grab a cup of stimulation and get started on the ever-growing to-do list. And, of course, here are some items to help you along. Have a great day and stay in touch... Merck KGgA Explores Risk Sharing Deals For Clinical Trials (The Financial Times) Roche To Spend $880M On Biologics Plant, Create 500 Jobs (Reuters) Teva Workers In Israel Threaten To Strike Over Planned Layoffs (Globes) Vivus Signs Auxilium To Market Erectile Dysfunction Drug In The US (Reuters) Celgene Warns UK Docs Of Birth Defect Risks With Blood Cancer Drug (Pharma Times) Cancer Is Costing European Union Countries Billions (BBC) Sanofi Gets FDA Approval To Sell Over-The-Counter Nasicort (Associated Press) EDITOR'S NOTE: Please check this post for additional stories during the day Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs